Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade

Lower Mortality ◽

Angiotensin Receptor ◽

Angiotensin System ◽

Nationwide Study ◽

Faculty Opinions recommendation of Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732240576.793542016 ◽

2018 ◽

Author(s):

Tahir Hussain

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Ace Inhibitors ◽

Lower Mortality ◽

Angiotensin Receptor ◽

Angiotensin System ◽

Nationwide Study ◽

Faculty Opinions recommendation of Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732240576.793540922 ◽

2017 ◽

Author(s):

Luis Ruilope ◽

Enrique Morales

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Ace Inhibitors ◽

Lower Mortality ◽

Angiotensin Receptor ◽

Angiotensin System ◽

Nationwide Study ◽

Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease

Life Sciences ◽

10.1016/j.lfs.2017.10.028 ◽

2017 ◽

Vol 191 ◽

pp. 175-179 ◽

Cited By ~ 5

Author(s):

Abel Esteves Soares ◽

Michael Maes ◽

Paula Godeny ◽

Andressa Keiko Matsumoto ◽

Décio Sabbatini Barbosa ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Vitamin D ◽

Kidney Disease ◽

Ace Inhibitors ◽

Angiotensin Receptor ◽

Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs)

British Journal of Clinical Pharmacology ◽

10.1111/j.1365-2125.2011.03918.x ◽

2011 ◽

Vol 71 (3) ◽

pp. 313-315 ◽

Cited By ~ 6

Author(s):

J. M. Ritter

Keyword(s):

Angiotensin Converting Enzyme ◽

Ace Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin System ◽

Renin Angiotensin ◽

Receptor Blockers ◽

Dual Blockade

The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?

Expert Opinion on Therapeutic Targets ◽

10.1517/14728222.11.2.191 ◽

2007 ◽

Vol 11 (2) ◽

pp. 191-205 ◽

Cited By ~ 19

Author(s):

Asterios Karagiannis ◽

Dimitri P Mikhailidis ◽

Vasilios G Athyros ◽

Anna I Kakafika ◽

Konstantinos Tziomalos ◽

...

Keyword(s):

Metabolic Syndrome ◽

Angiotensin Receptor ◽

Angiotensin System ◽

Renin Angiotensin ◽

Treatment Of Hypertension ◽

Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: Effect of angiotensin receptor blockers

Arthritis & Rheumatism ◽

10.1002/art.27384 ◽

2010 ◽

Vol 62 (5) ◽

pp. 1319-1328 ◽

Cited By ~ 33

Author(s):

Takeo Sakuta ◽

Yoshitaka Morita ◽

Minoru Satoh ◽

David A. Fox ◽

Naoki Kashihara

Keyword(s):

Rat Model ◽

Vascular Damage ◽

Angiotensin Receptor ◽

Angiotensin System ◽

Renin Angiotensin ◽

Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease

Expert Opinion on Investigational Drugs ◽

10.1517/13543784.2010.505918 ◽

2010 ◽

Vol 19 (9) ◽

pp. 1027-1037 ◽

Cited By ~ 8

Author(s):

Masanori Abe ◽

Kazuyoshi Okada ◽

Noriaki Maruyama ◽

Shiro Matsumoto ◽

Takashi Maruyama ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Calcium Channel ◽

Calcium Channel Blockers ◽

Channel Blockers ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

Reviewing the future of renin-angiotensin system blockade: The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation

Canadian Journal of Cardiology ◽

10.1016/s0828-282x(10)71170-3 ◽

2010 ◽

Vol 26 ◽

pp. 21E-23E ◽

Cited By ~ 4

Author(s):

Anique Ducharme ◽

Ernesto L Schiffrin

Keyword(s):

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Angiotensin System ◽

ADMINISTRATION-TIME-DEPENDENT EFFECTS OF ANGIOTENSIN RECEPTOR BLOCKERS IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASE

Journal of Hypertension ◽

10.1097/00004872-201106001-00737 ◽

2011 ◽

Vol 29 ◽

pp. e264

Author(s):

R. C. Hermida ◽

D. E. Ayala ◽

A. Mojon ◽

M. J. Fontao ◽

L. Chayan ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Time Dependent ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

Administration Time ◽

Genetic Variant of the Renin-Angiotensin System and Diabetes Influences Blood Pressure Response to Angiotensin Receptor Blockers

Diabetes Care ◽

10.2337/dc09-0348 ◽

2009 ◽

Vol 32 (8) ◽

pp. 1485-1490 ◽

Cited By ~ 25

Author(s):

T. Konoshita ◽

N. Kato ◽

S. Fuchs ◽

S. Mizuno ◽

C. Aoyama ◽

...

Keyword(s):

Blood Pressure ◽

Genetic Variant ◽

Blood Pressure Response ◽

Pressure Response ◽

Angiotensin Receptor ◽

Angiotensin System ◽

Renin Angiotensin ◽